Case Study

Mandatory Hub For Orphan-Designated Pediatric Therapy

Source: United BioSource LLC (UBC)

UBC engaged with a client whose product has Orphan Designation, and is Indicated for the treatment of Spinal Muscular Atrophy (SMA)-- SMA is caused by a mutation in the SMN1 gene, which encodes for a protein that motor neurons, need in order to survive. The mutation prevents this gene from producing any functional SMN protein which can lead to death or the need for mechanical ventilation by two years of age. Our client’s product is considered a life-saving therapy for patients and their families; however, it comes with a very high cost.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader